The Immune Tolerance Network (ITN) is a collaborative clinical research network funded by the National Institute of Allergy and Infectious Diseases, a part of the National Institutes of Health. Their mission is to develop therapeutic approaches for asthma and allergy, autoimmune diseases, type 1 diabetes, and solid organ transplantation that lead to immune tolerance.
With a focus on achieving durable clinical remission of autoimmune diseases, desensitization to allergen exposure, and inducing tolerance of transplanted organs without lifelong immunosuppression, the ITN conducts and funds clinical trials in immune tolerance. They aim to advance the clinical application of immune tolerance through their research and provide access to raw data, analysis, and clinical specimens through their TrialShare platform.
Generated from the website